Using Digital Technology for Sexual and Reproductive Health: Are Programs Adequately Considering Risk?

This commentary follows the publication of MSI’s randomised control trial in Bangladesh which showed that mHealth to promote contraceptive use increased women’s report of gender-based violence. The commentary describes why use of mobile technology entails risks, and outlines ways in which programmes can minimise risks to clients when communicating on sensitive sexual and reproductive health topics. These risks are essential for programmes to consider during the Covid epidemic too, since many health organisations are pivoting to digital strategies and remote communication, which may increase risk of inadvertent disclosure SRH service or product use.